Paladin Partners’s Teladoc Health TDOC Stock Holding History

Paladin Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$81	Hold	14	–	–	﹤0.01%	199
2026 Q2	$119	Hold	14	–	–	﹤0.01%	210
2026 Q1	$76	Hold	14	–	–	﹤0.01%	209
2025 Q4	$98	Buy	+14	New	+$110	﹤0.01%	213

Other funds holding TDOC

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 43.09% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Paladin Partners's TDOC Position: Q3 2026 in Review

Paladin Partners held its Teladoc Health (TDOC) position steady in Q3 2026 at 14 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #199.

Paladin Partners first reported a position in TDOC in Q4 2025 and has held it in 4 quarters since. The position peaked at $119 in Q2 2026. 9 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

Paladin Partners held 14 shares of Teladoc Health worth $81 as of Q3 2026.
Paladin Partners left its Teladoc Health share count unchanged in Q3 2026.
Teladoc Health made up ﹤0.01% of Paladin Partners's portfolio in Q3 2026, its #199 holding.
Paladin Partners first reported a position in Teladoc Health in Q4 2025 and has held it in 4 quarters since.
Paladin Partners's Teladoc Health position peaked at $119 in Q2 2026.
9 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Paladin Partners's 13F filing for Q3 2026, filed 6 Oct 2026.